» Articles » PMID: 5538703

Krabbe's Globoid Cell Leukodystrophy: Deficiency of Glactocerebrosidase in Serum, Leukocytes, and Fibroblasts

Overview
Journal Science
Specialty Science
Date 1971 Jan 8
PMID 5538703
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The activity of galactocerebroside beta-galactosidase was extremely low in serum, leukocytes, and cultured fibroblasts of patients with Krabbe's disease. Antemortem diagnosis is possible without organ biopsies. The parents of patients showed enzyme activities generally lower than that of normal controls. This finding provides supportive evidence that the deficient activity of galactocerebroside beta-galactosidase is the genetically determined enzymatic defect underlying the disease. Demonstration of this deficiency requires the use of the specific substrate, galactocerebroside. Assays carried out with synthetic, unnatural substrates, such as 4-methylumbelliferyl beta-galactoside, do not distinguish patients or heterozygous carriers from normal individuals.

Citing Articles

Nonhuman primate genetic models for the study of rare diseases.

Vallender E, Hotchkiss C, Lewis A, Rogers J, Stern J, Peterson S Orphanet J Rare Dis. 2023; 18(1):20.

PMID: 36721163 PMC: 9887761. DOI: 10.1186/s13023-023-02619-3.


Genotype and phenotype classification of 29 patients affected by Krabbe disease.

Madsen A, Wibrand F, Lund A, Ek J, Duno M, Ostergaard E JIMD Rep. 2019; 46(1):35-45.

PMID: 31240153 PMC: 6498822. DOI: 10.1002/jmd2.12007.


Characterization and application of a disease-cell model for a neurodegenerative lysosomal disease.

Ribbens J, Moser A, Hubbard W, Bongarzone E, Maegawa G Mol Genet Metab. 2013; 111(2):172-83.

PMID: 24094551 PMC: 3946682. DOI: 10.1016/j.ymgme.2013.09.011.


Immunostaining for oligodendrocyte-specific galactosphingolipids in fixed brain sections using the cholesterol-selective detergent digitonin.

Matsubayashi Y, Iwai L, Toda T, Lu Q, Kawasaki H J Neurosci Methods. 2008; 178(1):87-98.

PMID: 19100769 PMC: 4657755. DOI: 10.1016/j.jneumeth.2008.11.018.


The potential of stem cells for the treatment of brain tumors and globoid cell leukodystrophy.

Tunici P, Pellegatta S, Finocchiaro G Cytotechnology. 2008; 41(2-3):93-101.

PMID: 19002946 PMC: 3466696. DOI: 10.1023/A:1024818621377.